Additional Reduction in Serum Phosphorus Levels by Pulverized Lanthanum Carbonate Chewable in Hemodialysis Patients
Tetsuri Yamashita(Tokyo Women's Medical University Adachi Medical Center), Kosaku Nitta(Tokyo Women's Medical University), Masaki Takahashi(Tokyo Metropolitan Bokutoh Hospital), Takashi Kabaya(Senju Pharmaceutical (Japan)), Tetsuya Mitsuhashi, Junichi Shizuku, Naoshi Takahashi, Sayako Miyajima, Kuniaki Otsuka(University of Minnesota), Takashi Ohba(Kumamoto University), Tetsuya Ogawa(Nihon University)
Cited by 2
Related Papers
An Overview of Regular Dialysis Treatment in Japan (As of 31 December 2013)
|Therapeutic Apheresis and Dialysis|2015|425
Annual dialysis data report for 2018, JSDT Renal Data Registry: survey methods, facility data, incidence, prevalence, and mortality
|Renal Replacement Therapy|2020|170
Left Ventricular Hypertrophy Is Associated with Arterial Stiffness and Vascular Calcification in Hemodialysis Patients
|Hypertension Research|2004|161
Annual dialysis data report 2017, JSDT Renal Data Registry
|Renal Replacement Therapy|2019|158